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Scientific evidence in the field of psychiatry is mainly derived from group-based
(“nomothetic”) studies that yield group-aggregated results, while often the need
is to answer questions that apply to individuals. Particularly in the presence
of great inter-individual differences and temporal complexities, information at the
individual-person level may be valuable for personalized treatment decisions, individual
predictions and diagnostics. The single-subject study design can be used to make
inferences about individual persons. Yet, the single-subject study is not often used in
the field of psychiatry. We believe that this is because of a lack of awareness of its value
rather than a lack of usefulness or feasibility. In the present paper, we aimed to resolve
some common misconceptions and beliefs about single-subject studies by discussing
some commonly heard “facts and fictions.” We also discuss some situations in which
the single-subject study is more or less appropriate, and the potential of combining
single-subject and group-based study designs into one study. While not intending to
plea for single-subject studies at the expense of group-based studies, we hope to
increase awareness of the value of single-subject research by informing the reader about
several aspects of this design, resolving misunderstanding, and providing references for
further reading.
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INTRODUCTION
Scientific evidence in the field of psychiatry mainly relies on studies that evaluate what is true on
average in the population or a group. In many instances these studies yield valuable information,
but particularly when the goal is to improve patient care we need to answer questions that apply to
individual patients. For instance, if we want to know whether an antidepressant drug is effective in
a particular patient, it will not suffice to know that this drug results in an average reduction of 0.31
SD in depressive symptoms in the population (1). Also, knowing that at the group level depressive
symptoms are associated with increased levels of inflammatory markers (2) will not inform us
whether for a specific patient depressive symptoms will increase when levels of inflammatory
markers increase. It is increasingly being recognized that there are great inter-individual differences
in causes, risk factors, and course over time of psychiatric disorders and their symptoms, and their
response to treatments [e.g., (3, 4)].
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To illustrate the potential magnitude of this heterogeneity,
Figure 1 shows the course over time of depressive symptoms
weekly assessed over a period of 3 years in 267 persons who were
depressed at baseline [see for study details (5)]. The Figure shows
that there are great differences between persons in the trajectories
and that most persons show substantial fluctuations in symptom
levels over time. It seems that for very few persons the average
trajectory (left panel) applies, even were it to some extent. So,
one may wonder to what extent such group-level results will give
us information about what happens in most individual persons
studied in that group.
What the Figure shows is not an extraordinary pattern, and
many authors have noted the problem of relying on averages
when no subject is average [e.g., (6–12)]. Many phenomena we
study in the field of psychiatry are very heterogeneous across
people, and most phenomena are not static but are highly
dynamic (for example mood regulation and stress physiology). In
the presence of such great inter- and intra-individual variability,
information at the individual-person level may be of great
value for making personalized treatment decisions or identifying
personal predictors of changes in symptoms. Furthermore, in
order to grasp the highly dynamic nature of certain phenomena
we would need multiple repeated assessments across time. The
single-subject study is a useful study design that can be used to
make inferences about individual persons and to uncover the
highly dynamic nature of our variables of interest. Nevertheless,
this design is rarely used in the field of psychiatry. We think this
may be due to a lack of awareness of its value, which may be
partly due to a number of persistent misconceptions regarding
single-subject studies. In the present paper, we aim to increase
the recognition of the value of single-subject studies in the field
of psychiatry by discussing some major facts and fictions of
single-subject research.
Single-subject studies are characterized by their focus on
single persons. This is in contrast to most traditional group-based
(“nomothetic”) study designs, which focus on group averages
and compare (groups of) individuals with other individuals
(such as RCTs, cohort studies or case-control studies). In single-
subject studies, data of each individual are analyzed separately
and individuals are compared with themselves (13, 14). By
virtue of multiple assessments collected within one individual, an
individual can serve as his or her own control over time. This
allows to quantitatively examine whether changes in one variable
are systematically related to changes in another variable within
an individual (observational single-subject design), or whether
an experimental manipulation is related to a consistent change
within this individual (experimental single-subject design;
see Figure 2).
More generalizable conclusions can be obtained by replicating
multiple single-subject studies on a specific topic. In the presence
of great inter- and intra-individual variability, this will only
answer questions that apply to individual patients when each
participant is analyzed at the intra-individual level. If the same
effect is found in a series of single-subject studies, this could
potentially be the basis for a generalizable conclusion. That is,
the association might be true for the majority of persons [i.e.,
true in general; (15)]. In case of large heterogeneity, the chance of
finding such commonalities for processes underlying psychiatric
disorders might not be great. In that case, single-subject studies
can be used to link individual-level results to certain person
characteristics, or may be used in clinical practice to inform the
treatment process.
The single-subject study might be rare nowadays, it has
been used much in earlier centuries and has yielded important
information about human behavior, physiology and pathology
(see Box 1). The use of this design began to decline at the
beginning of the 20th century, when people became interested
in the improvement of species or races (27). In that time,
scientists (and eugenicists) like Pearson and Fisher introduced
statistical techniques focusing on group averages, therewith
fueling a paradigm shift toward group-aggregated results. This
shift toward statistics based on group averages was a logical step
to make if the interest is in improving species or plant varieties.
For example, if a farmer wants to know which factors improve
the growth of lettuce plants, he is not interested in the growth
of the individual lettuce plant, but rather in the average yield of
the whole field of lettuce plants. However, as we illustrated in the
first paragraph of this introduction, many questions in the field
of psychiatry apply to individual patients. The almost complete
disappearance of the single-subject study at the beginning of the
20th century therefore seems incompatible with the demand for
information that applies to individual persons in this field.
Although they are still relatively rare, in recent years single-
subject studies have been more frequently used in the field of
psychiatry, possibly due to innovations in ecological momentary
assessment (EMA), analytic methods, and technologies (28, 29).
Single-subject studies in the field of psychiatry have been applied
for several reasons (see Figure 2). First, observational single-
subject studies have been done to evaluate temporal associations
between variables that may be important in processes underlying
psychiatric disorders [e.g., (30–33)]. Such studies can yield very
useful information about potential risk and protective factors
at the individual level, which can increase scientific as well as
clinical insight. Some recent studies have elaborated on this,
and used single-subject research for developing personalized
diagnostics (34–40) and person-tailored treatment advice (41–
44). Another applicability of observational single-subject studies
is the examination of the temporal dynamics of single variables,
such as the variability or inertia (or autocorrelation, i.e.,
the degree to which successive observations are related to
each other). For instance, Wichers et al. revealed that an
increase in autocorrelation in negative affect preceded a relapse
of depression in a single patient (45). Thus, single-subject
studies can yield information that can be used for detecting
psychopathological changes or early warning signals. Another
application of the single-subject study is to evaluate the effects
and side effects of interventions in single individuals. In the
field of psychiatry such experimental single-subject studies
have evaluated, for example, the person-specific effects of
individualized cognitive therapy for depression in women with
metastatic cancer (46), pharmacological treatment for depression
(47), stimulants for ADHD in children (48), and treatments for
schizophrenia (49). Taken together, single-subject studies are and
can be used for different reasons in the field of psychiatry.
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FIGURE 1 | Weekly assessed depressive symptom severity over a period of 3 years in 267 persons who were initially depressed. Left: mean (95% CI) symptom
severity. Right: trajectories of the individual persons.
Despite a small recent increase in the use of the single-subject
study design, it is still relatively scarce in the field of psychiatry.
This is remarkable in a field that typically has to deal with a lot
of inter-individual heterogeneity and intra-individual variability,
and in which there is a high demand for results that apply to
individual patients. We believe that this is because of a lack
of awareness of the value of single-subject studies rather than
a lack of usefulness or feasibility. We will discuss several facts
and fictions regarding single-subject research, in order to resolve
some existing misconceptions about single-subject studies and
make the reader more aware of their value.
FACTS AND FICTIONS
We will now describe several statements that are often heard
from, for example, reviewers, members of ethical boards, funding
agencies, and colleague researchers. For each statement we
will explain whether we think it is a fact or fiction, and
elaborate on this.
Statement 1. Single-Subject Studies Are
Case Reports and Therefore Have No
Scientific Value
Fiction
Although single-subject and case reports both focus on
individuals (i.e., are both idiographic; see Figure 2), there are
some major differences. A case report is the presentation
of an interesting observation on a patient by the treating
specialist that lacks a pre-conceived design and systematic
assessments. Although case reports may be very informative for
generating hypotheses, the lack of systematic design elements
makes them prone to bias and invalid inference (14, 50). For
instance, a clinician may observe improvement in a depressed
patient after a certain therapy [e.g., (51)] and may attribute
this improvement to the therapy, while in reality it was due
to something else or a spontaneous recovery. Experimental
single-subject studies have specific design elements that help
elucidate whether the improvement is really due to the therapy.
They have a pre-conceived design with different cross-over
periods (intervention and control) and pre-planned assessments,
often done with validated instruments by an independent
researcher [for guidelines see (14, 17, 50, 52)].
Observational single-subject studies are also characterized by
a pre-planned design and systematic assessments of outcomes,
making them valuable for scientific research and clinical
diagnostics. For example, a patient might want to know
whether he generally feels more depressed after seeing his
mother in law. A single-subject observational study can answer
questions about such dynamic associations between variables
within one individual, which may go undetected in the clinical
care setting.
Thus, if a single-subject study is set up properly and has
enough observations to allow for statistical inference, it can yield
valid and reliable scientific and clinical evidence (13, 17, 23).
Statement 2. The Sample Size of
Single-Subject Studies Is Too Small to
Yield Enough Statistical Power
Fiction
An often-heard objection is that the sample size of single-subject
studies is too small. However, in single-subject studies time-series
data are analyzed for each individual separately. Because of this,
the power in single-subject studies depends on the number of
repeated observations within a person instead of the number of
persons. Thus, if the number of repeated observations within the
individual is large enough for the planned statistical analysis, the
power is sufficient. A variety of statistical methods exists for the
analysis of single-subject data [e.g., (29, 53, 54)].
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FIGURE 2 | Schematic illustration of different sorts of single-subject studies and some examples of aims of the two types of single-subject studies.
Statement 3. The Sample Size of
Single-Subject Studies Is Often Too Small
to Generalize Findings to the Population
Fact
While power of a single-subject study can be sufficient even
if n = 1 (see Statement 2), the sample size of single-subject
studies is still relevant for generalizability to the population.
One can only generalize findings to a population if it can be
demonstrated that the principle holds in all, or a large majority,
of a representative sample, which is not possible if n = 1.
However, in order to generalize the results of single-subject
studies, multiple single-subject studies can be performed in
individuals of the same population (direct replication), or in
different settings or populations (systematic replication) (55, 56).
Results of multiple single-subject studies may subsequently be
summarized using for instance meta-analysis (24, 57, 58). If the
ultimate goal is to gather scientific evidence concerning questions
that apply to individual persons, researchers can build a body of
single-case work, eventually leading to a large sample.
Statement 4. Group-Based Studies Are
More Suitable Than Single-Subject Studies
to Find Out What Is True in General
Fiction
Results from group-based studies yield information about what is
“true on average” and typically end up in standardized treatment
guidelines. However, in the presence of large inter- and intra-
individual differences, average effects are not informative on
whether a result is “true in general” (i.e., present in the majority
of the sample) (15). For instance, mood disorders are on average
associated with higher cortisol levels at the group level (59), but
this does not necessarily mean that worse mood is associated
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BOX 1 | The single-subject study has a long history.
Single-subject research is rather unpopular nowadays, except in some specific subfields of psychology (16). However, it used to be very common. At the end of the
19th century, “the intensive study of individuals” (also called “Idiographic research”) was themost popular scientific approach (15). The term “nomothetic” had a different
meaning in those days: nomothetic research was research aimed at establishing general laws and theories (10). It was thought that establishing general laws cannot be
donewithout describing and explaining particular events and individual processes. That is, in order to find out whether something is true for all or themajority of persons,
one must first describe and explain what holds for single individuals. Accordingly, nomothetic and idiographic research were seen as complementary. This changed in
the beginning of the 20th century. Inspired by famous statisticians and eugenicists like Pearson and Fisher, who introduced techniques like the correlation coefficient
and the normal distribution, the research focus shifted from the intensive study of individuals to the study of aggregates from large groups. The label “nomothetic”
came to stand for group-based research, and instead of focusing on what is common to all, analyses became focused on what is true “on average” (10, 15).1
Although seemingly old-fashioned, several useful findings have sprouted from the study of individuals, for example from quantitative research by Ebbinghaus, Pavlov,
Thorndike, Watson, and Shapiro, and qualitative research by Broca, James, Freud, Alzheimer, and Piaget, which has been described elegantly elsewhere (10, 17, 18).
One of the most famous adepts of the single-subject approach was Burrhus Skinner, who said that he would rather study one rat for a thousand times than a thousand
rats for 1 h each (19). Skinner studied how animal subjects (such as pigeons or rats) acquired certain behaviors in response to stimuli by rewarding or punishing the
animal (20). This work on operant conditioning revealed important knowledge of human behavior that is still applied nowadays for addressing clinical problems, such
as the treatment of addiction (21), and the development of cognitive behavioral and operant behavioral therapies (22). In medical sciences, single-subject studies are
still used occasionally, for example to examine the benefits or side effects of a drug in individual patients. Such “n-of-1 trials” have shown their potential in terms of
deciding whether a specific intervention works for a specific individual patient [e.g., (23–26)].
1In view of the ambiguous meaning of the word “nomothetic,” we use the term “group-based” throughout the paper when we refer to a study that focuses on
group-aggregated results.
with higher cortisol levels in the majority of individuals. A single-
subject study repeated in 30 individuals found great individual
differences in the within-subject association between mood and
cortisol levels (31). Thus, group-aggregated, averaged results are
not necessarily or very likely true for each individual in that
group. Moreover, the average may also be a poor reflection of
what is true for most individuals in the group, for example if
the distribution of parameters is bimodal or trimodal (60). Also
creating subgroups may not solve that problem, because we often
do not know by which characteristics we must define subgroups.
More formally, it has been shown that results obtained from
group-based studies can only be generalized to individuals when
the assumption of “ergodicity” is met. Ergodicity implies that
the average, variance, covariance and lagged covariance between
variables should be the same for all individuals (homogeneity),
and that no changes over time in these statistical characteristics
should be present (stationarity) (9, 61, 62). In the absence of
ergodicity, effects calculated at the group level, or even at a
more homogeneous subgroup level, will not generalize to the
individual level (7, 9, 12, 15, 63–65). An association found at
the (sub) group level may be weaker, stronger, absent or even
reversed in an individual (61). In fact, group-aggregated results
may sometimes not even apply to a single individual in that group
(10, 15).
Statement 5. Confounding in
Single-Subject Studies Is the Same as in
Group-Based Studies
Fiction
A point frequently raised by reviewers is that analyses of single-
subject studies should be adjusted for relevant demographic or
clinical variables. Indeed, these type of variables may confound
associations in group-based studies because they may differ
between individuals (between-subjects confounding). However,
in single-subject studies all variance in the outcome is due to
within-person variance in other variables, which may include
changes in environmental variables, events, lifestyle- or other
behaviors, treatments, etc. (61, 62). Therefore, in single-subject
studies variables can only confound an association if they vary
within the individual over time (within-subject confounding).
Variables that do not show fluctuations over time, such as sex
or a stable somatic condition, need (and can) not be adjusted
for in single-subject studies. While in group-based studies both
between- and within-subjects confounding may occur, in single-
subject studies only within-subject confounding may occur.
Only if one reverts to a group approach, for example by
combining results from multiple single-subject studies, group-
level covariates will become applicable again.
Statement 6. A Single-Subject Study
Cannot Establish Causality
Fact
It is not possible to establish causality using a single-subject
design. Moreover, this is also true for group-based study designs.
Hypothetically, the ideal experiment to determine the causal
effect of a certain treatment would be to expose an individual
to this treatment, observe what happens, and then go back in
time and expose the same individual to another condition (i.e.,
no treatment or placebo), all other things being equal (25, 66). Of
course, such a design is not possible as we cannot go back in time.
But interestingly, certain forms of single-subject studies come
close to this ideal experimental design: the n-of-1 randomized
controlled trials (n-of-1 RCTs). In these trials, various conditions
(e.g., treatment and placebo, or medicines with varying dosages)
are alternated over time and the order of exposure is determined
randomly. In this way, each individual serves as his or her own
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control. The strength of the design increases if multiple cross-
over periods are used and patients as well as clinicians and
researchers are blinded to the treatment order. A few studies
in the field of psychiatry have used such designs successfully
to examine the impact of interventions in single patients [e.g.,
(47–49, 67, 68)]. The deviation of this n-of-1 RCT from the
ideal counterfactual experiment is small and concerns only the
fact that the individual may have changed over time. In the
traditional group-based RCT, groups of people are compared
with each other, assuming these groups are similar. This latter
assumed similarity is a stronger assumption, and generally not
true (69) than the assumption that an individual is similar to
him- or herself somewhat earlier in time (66). Furthermore, n-
of-1 RCTs often include patients that do not meet the highly
selective inclusion criteria of group-based RCTs, and thus provide
information for patients for whom there is currently a lack
of evidence for treatment efficacy (47). Thus, the n-of-1 RCT
appears at least as ideal as the group-based RCT to establish
causality, and therefore deserves more attention in the scientific
field (25, 66, 70).
In addition to the n-of-1 RCT, other forms of single-subject
studies, such as ABA-designs or observational single-subject
studies can also contribute information that is important for
establishing causality, including strength of the association,
consistency of the association in different contexts and times,
specificity of the association, temporal precedence, and dose-
response relationship (71, 72). Because an individual serves as
his or her own control in all single-subject studies, it is possible
to determine in a systematic way the strength, consistency,
specificity and dose-response relation of an association within
that individual. Furthermore, because of the multitude of
repeated assessments in single-subject studies, the temporal order
of associations can be revealed (30, 31, 73–75). For example, it can
be revealed that changes in certain factors systematically precede
changes in other variables (i.e., temporal precedence). Even
though causality can probably never be completely established,
these aspects of single-subject studies are particularly helpful to
approach valid causal inference. Also sophisticated approaches
to establish causal inference via Directed Acyclic Graphs and
Structural Causal models can be applied to single-subject models
(76, 77), although these have very strict assumptions that are very
hard to meet in practice (77).
Statement 7. Single-Subject Research Is a
Lot of Work
Fact
An often-heard statement about single-subject research is that
it needs a lot of effort, which is true. Single-subject research
involves frequent/repeated assessment during a relatively long
period of time, which is time consuming and effortful for both the
participant, the researcher, and for therapists if they are involved.
However, due to recent technical innovations and increased
smartphone and sensor use, collecting ambulatory time-series
data has become more feasible. The feasibility has been shown
for healthy individuals (37), older adults (78, 79), and also for
patients with psychiatric disorders such as severe depression
or bipolar disorder (80), panic disorder (36), psychosis (81),
eating disorders (82) or ADHD (83). Data collection via a
smartphone is more convenient for the participant than paper-
and-pencil methods and makes laborious and error-prone data
entry unnecessary. The researcher mainly has to focus on data
cleaning, statistical analysis and (optionally) feedback generation,
for which nowadays more and more automated algorithms are
being developed [e.g., (84, 85)].
Single-subject research is also more feasible when
participating in a single-subject study is rewarding for
participants. For instance, revealing the personal treatment
effects or optimal dosage of a certain drug (47), or giving
diagnostic information through a personalized feedback report
(37, 41, 43) appeared particularly motivating to increase
compliance in clinical samples. Feedback reports can contain
descriptive feedback [e.g., (41)] or information about potential
triggers of symptoms based on statistical models [e.g., (36, 37)].
Although there are still many challenges that need to be resolved
(86), personalized feedback may reveal valuable insights for
patients and thus help to motivate them to complete the study.
Statement 8. One Can Just as Well Use
Multilevel Modeling in Order to Analyze
Data of a Group of Individuals
Fiction
In single-subject research, time series of each individual are
analyzed separately. But why not use multilevel modeling
instead? Multilevel modeling is a well-known tool for analyzing
longitudinal data collected in multiple persons, that also allows
to study within-person associations. While this is true, multilevel
methods still yield group-aggregated results. The fixed effects,
which are usually the main outcome of interest, represent the
average effect in the group. The fixed effects are a mix of
within- and between-person effects, but person-mean centering
of the predictors can be applied if we are interested in within-
person associations[(87); for examples of such studies, see (88–
94)]. However, such analyses still yield average within-person
associations. As discussed in Statement 4, the average may not
reflect what is true in general, i.e., for the majority of individuals.
If there is large heterogeneity in the sample, for example if
the distribution of parameters is bimodal or trimodal, or if the
functional form of the model differs across individuals, the fixed
effects will be a poor reflection of what holds for individuals
(60, 95, 96). As a corollary, also the random effects (the inter-
individual differences in the effects) may not be appropriate.
Random effects are post-hoc estimated deviations from the
average effects, and are assumed to be normally distributed
around these averages. If the latter are inaccurate, so will be the
random effects (60, 95, 96).
Furthermore, while person-mean centering is useful for
disaggregating between- and within-person effects of the
predictors, with respect to other model features within- and
between-person variance is more difficult to separate (for
example, the error covariance matrix) (97, 98). Recently,
new models like Dynamic Structural Equation Modeling (99),
or Bayesian Dynamic Modeling (96, 100, 101) do offer
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increased possibilities to adequately model other model features
within a multilevel framework. However, with increased model
complexity, for example with multiple interactions, feedback
loops, or non-linear effects, the problem of disaggregating
within- and between-person variance in multilevel models
becomes quite difficult. Analyzing data at the individual level
leaves more room for modeling such complexities (56, 95, 96).
Nevertheless, there are situations in which multilevel
modeling is the preferred statistical method. Multilevel models
have the advantage that they can “borrow strength” from
the data of other individuals (95, 101). This may be a great
advantage if individual time-series data are noisy, the number
of repeated measures is low, or the sample is homogeneous.
In such cases, multilevel models will yield better estimates
than single-subject analyses. A replicated single-subjects
approach may be the statistical method of choice in case of large
heterogeneity, many repeated observations, or high complexity
(33, 56, 60, 95, 96, 101).
DISCUSSION
Despite the relatively high demand for information applying to
individual persons, the single-subject study is not often used
in the field of psychiatry. We believe that this is because of a
lack of awareness of their value rather than a lack of usefulness
or feasibility. In the present paper we aimed to resolve some
common misconceptions and beliefs about single-subject studies
by discussing some commonly heard facts and fictions.
Single-subject studies can be particularly useful and have
additional value in several situations. For example, when there
are large inter-individual differences in the processes under study,
when these processes are very complex or nonlinear, or can
change over time. Additionally, single-subject studies have the
advantage that they may include any patient (also those with
complex or rare diseases), and (in the case of experimental single-
subject studies) are able to adjust the treatment when deemed
necessary (102, 103). This increases the ecological validity of
the single-subject study, and makes it particularly useful in
situations when large-group studies are not feasible; for instance
because the disease or event under study is rare, the patient
is complex (e.g., many comorbidities), the setting is complex
(e.g., palliative care), the intervention is highly expensive
or controversial, or the intervention contains person-specific
elements (46, 56, 102, 104, 105). Furthermore, single-subject
studies may involve patients more in their treatment process,
thereby increasing patient empowerment and shared decision
making (68). The single-subject study may also contribute
in the diagnostic process, to evaluate factors contributing to
treatment responses, or to evaluate efficacy of certain treatments
(34, 38–41, 43, 44). Practically, this has led to the recent
development of algorithms and clinical care applications that
implement single-subject analyses in the diagnostic process in
clinical care settings [(42, 44, 106) conference abstract]. Single-
subject studies can also be used to obtain a detailed description
of a particular approach applied to an individual in order to
test an existing clinical theory [theory exemplification; (107)].
While group-based studies often only study a limited number
of aspects belonging to a theory, a single-subject study can map
in detail all its aspects together in one person. For example,
a single-subject study could detail all processes underlying
response to cognitive therapy in a specific patient [e.g. (108)],
thereby showing how to optimally apply an existing theory
underlying cognitive therapy. Complex statistical models can
be linked to processes underlying psychiatric disorders [for
example how a panic attack evolves in a specific patient,
(109)], which may help in understanding their mechanism in
individual patients.
Despite these advantages of single-subject studies, group-
based studies are more appropriate if one wants to make
inferences about average tendencies in the population, such as
the prevalence, incidence or average risk of a disorder, or the
average effect of certain treatments in the whole population or
a certain subpopulation. For instance, if one wants to know
whether legalizing cannabis helps in reducing the prevalence or
incidence of psychotic disorders in the population. Moreover,
group-based studies are more appropriate if individual time-
series data are very short or noisy, or the process under study is
homogeneous across individuals (33, 95, 101). Thus, group-based
and single-subject studies can both be useful and are appropriate
in different situations.
In some circumstances, the group-based and single-subject
approach may be combined. A first reason for combining these
designs is to identify commonalities across persons, in order to
increase generalizability to the population. Practically this can
be done by combining group- and individual-level analyses in
one model, for example using Group Iterative Multiple Model
Estimation [GIMME (60)], or meta-analytical techniques for
pooling data from multiple single-subject studies (57, 58, 110).
Related to this, pooling data from multiple single-subject studies
can be used to link individual-level results to certain between-
subjects characteristics. For instance, results from multiple
experimental single-subject studies may be pooled and linked
to patient characteristics in order to identify which patient
characteristics are associated with better outcomes of a certain
treatment (103). Likewise, data from multiple observational
single-subject studies may be pooled in order to identify whether
person-specific associations between variables can be linked
to certain patient characteristics such as the presence of a
depressive disorder [e.g. (31, 73, 111)], or different severity
of depressive symptoms (112). Another reason to combine
the single-subject with the group-based approach would be
to examine the group-level effectiveness of an individualized
treatment or lifestyle advice that is based on single-subject
analyses of diary observations [e.g., (43, 44)]. In this way,
the single-subject study design can be of added value to the
increasing urge for personalized patient care in mental health
care settings (29, 113–115).
CONCLUSION
In the field of psychiatry, single-subject studies are still relatively
scarce. We hope that we have resolved some misunderstandings
surrounding single-subject studies and have increased the
reader’s awareness of possibilities and impossibilities of the
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single-subject design. Although single-subject studies are
definitely not suitable in all circumstances, we believe that they
deserve more attention in the field of psychiatry, especially in
view of the current urge for personalized patient care, increased
importance of shared decision making, increased availability
of electronic devices and sensors, and recent advancements in
analytic methods for time-series data.
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